Glucotrack regains Nasdaq compliance with stockholders' equity rule

Go back to Glucotrack regains Nasdaq compliance with stockholders' equity rule

Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation

August 17, 2026 8:00 AM EDT

RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)-- Glucotrack, Inc. (Nasdaq: GCTK) today announced that the Nasdaq Hearings Panel has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to certain conditions. The Panel has confirmed that Glucotrack has regained compliance with Nasdaq's stockholders' equity requirement. The decision represents an important milestone in the Company's efforts to strengthen its foundation and position for future growth.

This is an important milestone, but more significantly, it is an acknowledgment of the substantial progress we have made in repositioning... More